Chinese beauty giants like Proya and S’Young are actively pursuing acquisitions of smaller foreign brands as domestic growth slows and competition intensifies. Seeking to replicate the success of global leaders such as L’Oreal and Estée Lauder, these brands aim to diversify revenue streams and build international portfolios.
Proya, known for its science-driven, affordable skincare, became the first Chinese beauty brand to surpass 10 billion yuan ($1.38 billion) in annual revenue in 2024. Founder Hou Juncheng recently revealed plans to join the global top ten by 2034, targeting 50 billion yuan ($7 billion) in yearly revenue—similar to Japan's Shiseido. The company plans to acquire European beauty brands with strong heritage and technology.
Meanwhile, S’Young and Ushopal have already made inroads abroad. S’Young owns French skincare label Evidens de Beaute and U.S. brand ReVive, while Ushopal has added Payot, ARgENTUM, and Juliette Has a Gun to its portfolio. Ushopal aims to acquire one to two new brands each year.
Experts say Chinese brands will likely target premium European skincare, fragrance, or haircare companies valued under $500 million. However, challenges remain. Past efforts by Chinese fashion groups to expand globally—such as state-owned Ruyi’s failed luxury acquisitions—highlight the risks of managing foreign brands.
Ushopal’s William Lau noted that global M&A is inherently difficult and warned against altering a brand’s identity post-acquisition. Preserving brand DNA, while leveraging Chinese capital and distribution, may be the key to sustainable global success.
With the global beauty market projected to reach $677 billion in 2025, compared to $42 billion in China, international expansion is becoming essential. Analysts predict the rise of a Chinese L’Oreal or Estée Lauder in the near future.


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Samsung Electronics Shares Jump on HBM4 Mass Production Report 



